Vitestro Secures $22 Million (€20 million) for Autonomous Blood Draw Device
30 avr. 2024 07h00 HE
|
Vitestro
Vitestro lands $22M to ramp up commercialization efforts for robotic blood draw device
Global Vein Illuminator Market to Reach USD 327.2 Million by 2028 - Rising Demand of Vein Illuminator from Hospitals to Boost Market - Exclusive Report by Vantage Market Research
31 janv. 2022 06h33 HE
|
Vantage Market Research
WASHINGTON, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Vein Illuminator Market finds that mounting demand of Vein Illuminator from hospitals is...
Moffitt Cancer Center Advances Patient Standard of Care by Introducing Needleless Blood Draws
24 mars 2021 10h00 HE
|
Moffitt Cancer Center
TAMPA, Fla., March 24, 2021 (GLOBE NEWSWIRE) -- Moffitt Cancer Center has adopted a new needle-free method of blood collection for patients in treatment who often need to undergo repeated needle...
Holy Name Medical Center Launches One-Stick Hospitalization as New Inpatient Standard of Care
11 févr. 2021 08h00 HE
|
Holy Name Medical Center
TEANECK, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Holy Name Medical Center today announced that it is the first hospital in New Jersey among a growing number of health systems nationwide to offer...
Velano Vascular Named Top Impact Company for 2021 by Real Leaders
13 janv. 2021 09h00 HE
|
Velano Vascular
Velano recognized for pioneering a more humane standard of care for hospital patients; follows on heels of being named fastest growing medical device company in the U.S. and one of world’s most...
Velano Secures Additional Funding to Meet Commercial Demand for PIVO, Fueled by Industry Move to One-Stick Hospitalization
17 déc. 2019 07h00 HE
|
Velano Vascular
- Latest funding caps year of groundbreaking milestones for transformative vascular access company; new capital will be used to meet rapidly growing hospital and patient demand - SAN FRANCISCO, Dec. ...
Velano Vascular Receives Frost & Sullivan’s 2019 North America Product Leadership Award for Needle-free Venous Access Technology
20 nov. 2019 08h00 HE
|
Velano Vascular
SAN FRANCISCO, Nov. 20, 2019 (GLOBE NEWSWIRE) -- Vascular access technology pioneer Velano Vascular today announced that it has been named the Frost & Sullivan 2019 North American Product...
Velano Primes for Growth with Funding from Intermountain Healthcare and Notable Individual Investors to Transform Blood Collection Globally
08 mai 2019 07h00 HE
|
Velano Vascular
SAN FRANCISCO, May 08, 2019 (GLOBE NEWSWIRE) -- Vascular access technology pioneer Velano Vascular today announced that it has secured $10 million as the initial tranche of a growth financing to...
Velano Named One of Fast Company’s 2019 Top Ten Most Innovative Companies in Biotech for Pioneering Better Blood Draws
20 févr. 2019 10h06 HE
|
Velano Vascular
SAN FRANCISCO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Vascular access technology pioneer Velano Vascular has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies...
Velano Adds to Leadership Team and Advisory Board to Accelerate Adoption of Novel Human-Centered Standard of Care for Inpatient Blood Draws
05 déc. 2018 08h00 HE
|
Velano Vascular
SAN FRANCISCO, Dec. 05, 2018 (GLOBE NEWSWIRE) -- Vascular access technology innovator Velano Vascular continues to aggressively expand in pursuit of its mission to dramatically remake blood...